Abstract

In hepatitis C Virus (HCV) high-risk groups, HCV-specific T cell responses have been detected in seronegative, aviremic persons who have no evidence of HCV infection. Herein, we investigated functional profiles of HCV-specific T-cell responses in seronegative, aviremic patients of a HCV high-risk group. Seventy seven hemodialysis patients with chronic renal disease were analyzed by IFN-γ ELISpot assays, and eight of 71 (11.3%) seronegative, aviremic patients displayed HCV-specific T-cell responses. Their HCV-specific memory T cells were characterized by assessing cytokine polyfunctionality, known to provide antiviral protection. By intracellular staining of IFN-γ, TNF-α, IL-2 and MIP-1β, we identified two distinct populations in the seronegative, aviremic patients: polyfunctional responders and TNF-α-predominant responders. In further analysis, occult HCV infection was excluded as a cause of the HCV-specific T cell response via secondary nested RT-PCR of HCV RNA in peripheral blood mononuclear cell samples. HCV-specific T cells targeted multiple epitopes including non-structural proteins in a single patient, implying that their T cells might have been primed by HCV proteins synthesized within the host. We conclude that HCV-specific memory T cells of seronegative, aviremic patients arise from authentic HCV replication in the host, but not from current occult HCV infection. By functional pattern of HCV-specific T cells, there are two distinct populations in these patients: polyfunctional responders and TNF-α-predominant responders.

Highlights

  • Hepatitis C virus (HCV) infection is a major cause of chronic viral hepatitis that often progresses to liver cirrhosis and hepatocellular carcinoma [1]

  • Among 77 hemodialysis patients with chronic renal disease, one patient was seropositive without viremia, and five patients were seropositive with viremia

  • HCV-specific T cell responses were evaluated by direct ex vivo IFN-c enzyme-linked immunosorbent spot (ELISpot) assay of Peripheral blood mononuclear cells (PBMCs) in all patients except the seropositive, aviremic patient

Read more

Summary

Introduction

Hepatitis C virus (HCV) infection is a major cause of chronic viral hepatitis that often progresses to liver cirrhosis and hepatocellular carcinoma [1]. HCV-specific T cell responses in seronegative, aviremic persons have been detected mainly in HCV high-risk groups such as IDUs, residents of HCV-endemic areas, healthy family members of HCV-infected patients, and healthcare workers [7,8,9,10,11,12,13]. It remains unclear why HCV-specific T cells are primed in seronegative, aviremic persons. Detailed characteristics of HCV-specific T cells have not been previously identified in seronegative, aviremic persons

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.